Hikma Pharmaceuticals PLC HKMPY Stock
Hikma Pharmaceuticals PLC Price Chart
Hikma Pharmaceuticals PLC HKMPY Financial and Trading Overview
| Hikma Pharmaceuticals PLC stock price | 47.13 USD |
| Previous Close | 47.6 USD |
| Open | 47.6 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 47.6 - 47.6 USD |
| 52 Week Range | 25.12 - 47.6 USD |
| Volume | 329 USD |
| Avg. Volume | 395 USD |
| Market Cap | 5.25B USD |
| Beta (5Y Monthly) | 0.390038 |
| PE Ratio (TTM) | 28.502995 |
| EPS (TTM) | 1.7 USD |
| Forward Dividend & Yield | 1.12 (2.35%) |
| Ex-Dividend Date | March 23, 2023 |
| 1y Target Est | N/A |
HKMPY Valuation Measures
| Enterprise Value | 6.25B USD |
| Trailing P/E | 28.502995 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.0868733 |
| Price/Book (mrq) | 2.4551268 |
| Enterprise Value/Revenue | 2.481 |
| Enterprise Value/EBITDA | 8.186 |
Trading Information
Hikma Pharmaceuticals PLC Stock Price History
| Beta (5Y Monthly) | 0.390038 |
| 52-Week Change | 26.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 47.6 USD |
| 52 Week Low | 25.12 USD |
| 50-Day Moving Average | 45.66 USD |
| 200-Day Moving Average | 38.6 USD |
HKMPY Share Statistics
| Avg. Volume (3 month) | 395 USD |
| Avg. Daily Volume (10-Days) | 440 USD |
| Shares Outstanding | 110.35M |
| Float | 77.01M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.56 |
| Trailing Annual Dividend Yield | 1.17% |
| 5 Year Average Dividend Yield | 188.00% |
| Payout Ratio | 0.65790004 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.46% |
| Operating Margin (ttm) | 23.48% |
| Gross Margin | 50.25% |
| EBITDA Margin | 30.31% |
Management Effectiveness
| Return on Assets (ttm) | 8.35% |
| Return on Equity (ttm) | 8.27% |
Income Statement
| Revenue (ttm) | 2.52B USD |
| Revenue Per Share (ttm) | 22.47 USD |
| Quarterly Revenue Growth (yoy) | -2.50% |
| Gross Profit (ttm) | 1.27B USD |
| EBITDA | 763M USD |
| Net Income Avi to Common (ttm) | 188M USD |
| Diluted EPS (ttm) | 1.67 |
| Quarterly Earnings Growth (yoy) | -91.29% |
Balance Sheet
| Total Cash (mrq) | 292M USD |
| Total Cash Per Share (mrq) | 2.65 USD |
| Total Debt (mrq) | 1.28B USD |
| Total Debt/Equity (mrq) | 59.73 USD |
| Current Ratio (mrq) | 1.856 |
| Book Value Per Share (mrq) | 19.388 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 530M USD |
| Levered Free Cash Flow (ttm) | 299.5M USD |
Profile of Hikma Pharmaceuticals PLC
| Country | United States |
| State | N/A |
| City | London |
| Address | 1 New Burlington Place |
| ZIP | W1S 2HR |
| Phone | 44 20 7399 2760 |
| Website | https://www.hikma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 8800 |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.
Q&A For Hikma Pharmaceuticals PLC Stock
What is a current HKMPY stock price?
Hikma Pharmaceuticals PLC HKMPY stock price today per share is 47.13 USD.
How to purchase Hikma Pharmaceuticals PLC stock?
You can buy HKMPY shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hikma Pharmaceuticals PLC?
The stock symbol or ticker of Hikma Pharmaceuticals PLC is HKMPY.
Which industry does the Hikma Pharmaceuticals PLC company belong to?
The Hikma Pharmaceuticals PLC industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hikma Pharmaceuticals PLC have in circulation?
The max supply of Hikma Pharmaceuticals PLC shares is 110.94M.
What is Hikma Pharmaceuticals PLC Price to Earnings Ratio (PE Ratio)?
Hikma Pharmaceuticals PLC PE Ratio is 27.72353000 now.
What was Hikma Pharmaceuticals PLC earnings per share over the trailing 12 months (TTM)?
Hikma Pharmaceuticals PLC EPS is 1.7 USD over the trailing 12 months.
Which sector does the Hikma Pharmaceuticals PLC company belong to?
The Hikma Pharmaceuticals PLC sector is Healthcare.